quinazolines has been researched along with Fetal Growth Retardation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, N; Ishii, K; Mori, A; Morita, A; Nagamitsu, T; Nakahara, T; Sakamoto, K; Wada, Y | 1 |
| Abe, N; Ishii, K; Kurauchi, Y; Mori, A; Morita, A; Nagamitsu, T; Nakahara, T; Sakamoto, K | 1 |
| Abe, N; Ishii, K; Nagamitsu, T; Nakahara, T; Ohta, H; Ozaki, H; Wada, Y | 1 |
3 other study(ies) available for quinazolines and Fetal Growth Retardation
| Article | Year |
|---|---|
KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces intrauterine growth restriction in mice.
Topics: Animals; Animals, Newborn; Female; Fetal Growth Retardation; Intestine, Small; Kidney; Lymphoid Tissue; Male; Mice; Pancreas; Phenylurea Compounds; Placenta; Pregnancy; Protein Kinase Inhibitors; Quinazolines; Receptors, Vascular Endothelial Growth Factor | 2013 |
Treatment of mid-pregnant mice with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, induces abnormal retinal vascular patterning in their newborn pups.
Topics: Animals; Animals, Newborn; Female; Fetal Growth Retardation; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Phenylurea Compounds; Pregnancy; Quinazolines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Retinal Vessels | 2014 |
Effects of KRN633, an inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase, on vascular development of placenta and fetus of mid-pregnancy in mice.
Topics: Animals; Female; Fetal Growth Retardation; Fetus; Mice; Mice, Inbred ICR; Phenylurea Compounds; Placenta; Pregnancy; Pregnancy Trimester, Second; Protein Kinase Inhibitors; Quinazolines; Vascular Endothelial Growth Factor Receptor-2 | 2010 |